Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Predictive identification of human skin sensitization thresholds.

Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I.

Contact Dermatitis. 2005 Nov;53(5):260-7.

PMID:
16283904
2.

Skin sensitization testing in potency and risk assessment.

Kimber I, Basketter DA, Berthold K, Butler M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C.

Toxicol Sci. 2001 Feb;59(2):198-208. Review.

PMID:
11158712
3.

Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.

Gerberick GF, Ryan CA, Dearman RJ, Kimber I.

Methods. 2007 Jan;41(1):54-60. Review.

PMID:
16938465
4.

The local lymph node assay and the assessment of relative potency: status of validation.

Basketter DA, Gerberick F, Kimber I.

Contact Dermatitis. 2007 Aug;57(2):70-5. Review.

PMID:
17627643
5.

The local lymph node assay: past, present and future.

Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF.

Contact Dermatitis. 2002 Dec;47(6):315-28. Review.

PMID:
12581276
6.

Potency values from the local lymph node assay: application to classification, labelling and risk assessment.

Loveless SE, Api AM, Crevel RW, Debruyne E, Gamer A, Jowsey IR, Kern P, Kimber I, Lea L, Lloyd P, Mehmood Z, Steiling W, Veenstra G, Woolhiser M, Hennes C.

Regul Toxicol Pharmacol. 2010 Feb;56(1):54-66. doi: 10.1016/j.yrtph.2009.08.016. Review.

PMID:
19733604
7.

In vitro approaches to the identification and characterization of skin sensitizers.

Basketter D, Maxwell G.

Cutan Ocul Toxicol. 2007;26(4):359-73. Review.

PMID:
18058309
8.
9.

Local lymph node assay: validation assessment for regulatory purposes.

Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA.

Am J Contact Dermat. 2000 Mar;11(1):3-18. Review.

PMID:
10684384
10.

Local lymph node assay: use in hazard and risk assessment.

Dearman RJ, Basketter DA, Kimber I.

J Appl Toxicol. 1999 Sep-Oct;19(5):299-306. Review.

PMID:
10513674
11.
12.

Skin irritation and sensitization: mechanisms and new approaches for risk assessment.

Basketter D, Darlenski R, Fluhr JW.

Skin Pharmacol Physiol. 2008;21(4):191-202. doi: 10.1159/000135635. Review.

13.

Skin sensitisation, vehicle effects and the local lymph node assay.

Basketter DA, Gerberick GF, Kimber I.

Food Chem Toxicol. 2001 Jun;39(6):621-7. Review.

PMID:
11346493
14.

Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment.

Basketter DA.

Cutan Ocul Toxicol. 2010 Mar;29(1):4-9. doi: 10.3109/15569520903351151. Review.

PMID:
19883218
15.

Thresholds in contact sensitization: immunologic mechanisms and experimental evidence in humans--an overview.

Boukhman MP, Maibach HI.

Food Chem Toxicol. 2001 Dec;39(12):1125-34. Review.

PMID:
11696387
16.

Skin sensitization thresholds: determination in predictive models.

Basketter DA, Cookman G, Gerberick GF, Hamaide N, Potokar M.

Food Chem Toxicol. 1997 Mar-Apr;35(3-4):417-25. Review.

PMID:
9207904
17.
18.

Skin sensitization: strategies for the assessment and management of risk.

Basketter DA.

Br J Dermatol. 2008 Aug;159(2):267-73. doi: 10.1111/j.1365-2133.2008.08625.x. Review.

PMID:
18503602
19.

Categorization of chemicals according to their relative human skin sensitizing potency.

Basketter DA, Alépée N, Ashikaga T, Barroso J, Gilmour N, Goebel C, Hibatallah J, Hoffmann S, Kern P, Martinozzi-Teissier S, Maxwell G, Reisinger K, Sakaguchi H, Schepky A, Tailhardat M, Templier M.

Dermatitis. 2014 Jan-Feb;25(1):11-21. doi: 10.1097/DER.0000000000000003. Review.

PMID:
24407057
20.

The importance of exposure estimation in the assessment of skin sensitization risk.

Robinson MK, Gerberick GF, Ryan CA, McNamee P, White IR, Basketter DA.

Contact Dermatitis. 2000 May;42(5):251-9. Review.

PMID:
10789838

Supplemental Content

Support Center